Sign in

CIK 0000072444 · Accelerated filer<br>Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
591212264
Phone
(650) 550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. SC 13G/A Stake Amended Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 8-K Event Executive or director change
  4. 8-K Event Exit or restructuring costs
  5. 8-K Event Other events
  6. 8-K Event Executive or director change · Shareholder vote results
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. DEFA14A Proxy Proxy Materials
  11. EFFECT Other Notice of Effectiveness
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-3/A Offering Registration Statement
  14. DEF 14A Proxy Proxy Statement
  15. 10-K Report Annual Report
  16. PRE 14A Proxy Proxy Statement (Preliminary)
  17. 8-K Event Results of operations
  18. NT 10-K Other NT 10-K
  19. 8-K Event Executive or director change
  20. UPLOAD Other SEC-generated Letter

Page 42 of 89 · 1,773 filings